Rob Lauzen

Rob Lauzen is an experienced finance and investment professional currently serving as Vice President of Investor Relations and Head of FP&A at Dyne Therapeutics since September 2021. Prior to this role, Rob held various positions at Morgan Stanley from June 2015 to September 2021, including Healthcare Investment Banking Vice President, Associate, and Analyst. Additionally, Rob co-founded DiagnosMe LLC from January 2013 to January 2015 and worked as a Winter Analyst in the Healthcare Investment Banking Group at Morgan Stanley in early 2014. Rob earned a Bachelor of Arts in Engineering from Dartmouth College, graduating in 2015.